Go to 4nrx Pharmacy Start Page
 
 
 
 
Shopping Cart       Items: 0       Subtotal: £ 0 Search
Home Antiviral MyHep All (Sofosbuvir/Velpatasvir)

Pharmacy Catalogue

   
Accessories  
Allergies  
Antidepressants  
Antiviral  
Arthritis  
Asthma  
Cancer  
Diabetes  
Erectile Dysfunction (ED)  
Eyes  
General Health  
Generics  
Hair  
Heart  
HIV Treatments  
Infection  
Men`s Health  
Milk Supply  
Neurological Health  
Pain  
Skin  
Stomach  
Substance Abuse  
Thyroid  
Weight Loss  
Women`s Health  
4NRX Pet Pharmacy  
 
Free Shipping
* Free shipping on orders over £50.00
Shopping Discount
* Up to £15.00 off for returning customers on orders over £450.00
Go to Secure SSL/HTTPS 4nrx-uk.md

MyHep All (Sofosbuvir/Velpatasvir)

Image Product Name
MyHep All (Sofosbuvir/Velpatasvir) - 400mg/100mg (28 Tablets)

£290.00 | * Out of Stock,please contact us for availability

 
Active Ingredient(s)

Sofosbuvir/Vepatasvir

Manufacturer

Mylan

Country of Origin

India

Reference

N/A

What is MyHep All (Sofosbuvir/Velpatasvir) used for?

MyHep All (Sofosbuvir/Velpatasvir) is combination of two antiviral substances used in the treatment of hepatitis C.

Sofosbuvir is a pangenotypic inhibitor of the RNA-dependent RNA polymerase NS5B of the hepatitis C virus (HCV) required for viral replication.

Sofosbuvir is a nucleotide prodrug that undergoes intracellular metabolism to form a pharmacologically active uridine triphosphate analogue (GS-461203). Using NS5B polymerase, GS-461203 can be inserted into the HCV RNA chain under construction and act as a chain terminator. This active metabolite of sofosbuvir (GS-461203) suppressed the polymerase activity of HCV genotypes 1b, 2a, 3a, and 4a at concentrations that caused 50% inhibition (IC50) of virus in the range from 0.7 to 2.6 ?mol.

The active metabolite of sofosbuvir (GS-461203) does not inhibit human DNA and RNA polymerase and human mitochondrial RNA polymerase.

Velpatasvir also has antiviral activity against the hepatitis C virus. It affects the NS5A protein, and thus helps reduce viral load.

How should I use MyHep All (Sofosbuvir/Velpatasvir)?

Always follow your doctor`s instructions when using MyHep All (Sofosbuvir/Velpatasvir) to get the safest and most effective results from treatment.

As a rule, the dosage is 1 tablet once a day.

Duration of treatment is 12 weeks.

What are the side effects of MyHep All (Sofosbuvir/Velpatasvir)?

The use of MyHep All (Sofosbuvir/Velpatasvir) may cause side effects in some patients, such as headache, fatigue, nausea.

However, it should be noted that similar and other side effects occurred with such frequency when used in the placebo group.

Please Note

There is insufficient data (less than 300 outcomes of pregnancies) on the use of MyHep All (Sofosbuvir/Velpatasvir) during pregnancy. MyHep All (Sofosbuvir/Velpatasvir) should be avoided during pregnancy.

The results of preclinical studies did not reveal the direct or mediated reproductive toxicity of sofosbuvir.

It is not known whether MyHep All (Sofosbuvir/Velpatasvir) and its metabolites penetrate into human breast milk, although the excretion of metabolites in breast milk has been established in preclinical studies.

Since the risk to the newborn cannot be ruled out, MyHep All (Sofosbuvir/Velpatasvir) should not be used during breastfeeding.